Patents by Inventor Walid M. Awni

Walid M. Awni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of attention-deficit/hyperactivity disorder
    Patent number: 8222278
    Abstract: 3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.
    Type: Grant
    Filed: May 29, 2009
    Date of Patent: July 17, 2012
    Assignee: Abbott Laboratories
    Inventors: Earle E. Bain, Walid M. Abi-Saab, Sandeep Dutta, Tushar S. Garimella, Walid M. Awni, Mario D. Saltarelli
  • METHODS FOR TREATING PSORIASIS
    Publication number: 20110206680
    Abstract: The invention provides methods of treating psoriasis in a subject by administering to a subject an antibody capable of binding to the p40 subunit of IL-12 and/or IL-23.
    Type: Application
    Filed: September 14, 2010
    Publication date: August 25, 2011
    Applicants: ABBOTT LABORATORIES, ABBOTT GMBH & CO., KG
    Inventors: JOAQUIN MARIO VALDES, ELLIOT K. CHARTASH, WILLIAM T. BARCHUK, SUSAN K. PAULSON, KENNETH B. GORDON, WALID M. AWNI, YANJUN BAO, WILLIAM G. GLASS, YIHUA GU, TOM C. HARRIS, MARTIN KAUL, PARVEZ M. MULANI, PETER NOERTERSHEUSER, MARTIN M. OKUM
  • TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Publication number: 20100144795
    Abstract: 3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-deficit/hyperactivity disorder.
    Type: Application
    Filed: May 29, 2009
    Publication date: June 10, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Earle E. Bain, Walid M. Abi-Saab, Sandeep Dutta, Tushar S. Garimella, Walid M. Awni, Mario D. Saltarelli